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Abstrat
Many users of mortality models are interested in using them to
plae values on longevity-linked liabilities and seurities. Modern reg-
ulatory regimes require that the values of liabilities and reserves are
onsistent with market pries (if available), whilst the gradual emer-
gene of a traded market in longevity risk needs methods for priing
new types of longevity-linked seurities quikly and eiently. In this
study, we develop a new forward mortality framework to enable the ef-
ient priing of longevity-linked liabilities and seurities in a market-
onsistent fashion. This approah starts from the historial data of
the observed mortality rates, i.e., the fore of mortality. Building on
the dynamis of age/period/ohort models of the observed fore of
mortality, we develop models of forward mortality rates and then use
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a hange of measure to inorporate whatever market information is
available. The resulting forward mortality rates are then used to value
a number of dierent longevity-linked seurities, suh as q-forwards,
s-forwards and longevity swaps.
JEL Classiation: G12
Keywords: Mortality modelling, age/period/ohort models, forward
mortality rates, Essher transform, longevity-linked seurities
1 Introdution
Many users of mortality models are interested in using them to plae val-
ues on longevity-linked liabilities and seurities. Modern regulatory regimes
require that the values of liabilities and reserves are onsistent with mar-
ket pries (if available), whilst the gradual emergene of a traded market in
longevity risk needs methods for priing new types of longevity-linked seu-
rities quikly and eiently. These needs have spurred the development of
inreasingly sophistiated models of mortality rates.
Cairns et al. (2006b) pointed out that the majority of mortality mod-
els that have been proposed are models of the mortality hazard rate, whih
is analogous to the short rate of interest. By analogy with interest rate
models, Cairns et al. (2006b) developed formally the onept of mortality
forward rates, whih was extended in Miltersen and Persson (2005). How-
ever, the idea of forward mortality rates has a long history, indeed Milevsky
and Promislow (2001) pointed out that the traditional rates used by atu-
aries are really `forward rates' exatly analogous to a forward interest rate
implied by existing bond pries.
Suh forward mortality rates ould be used to prie longevity-linked se-
urities, in the same fashion as forward interest rates are used to value ash-
ows dependent on future interest rates. Therefore, a number of models for
forward mortality rates have been proposed to date whih build upon the
theory of forward interest rates. These have inluded the models of Barbarin
(2008), Bauer et al. (2008) and Tappe and Weber (2013), whih adopted
the Heath-Jarrow-Morton framework used for interest rates in ontinuous
time, and the model of Zhu and Bauer (2011a,b, 2014) whih adopted a
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semi-parametri fator approah in disrete time. An alternative approah,
developed in Olivier and Jerey (2004), Smith (2005) and Cairns (2007),
also works in disrete time but uses gamma-distributed random variables to
update a forward mortality surfae that is initially assumed.
However, it is important not to over-extend the analogy between interest
rates and mortality rates, as the two are fundamentally dierent proesses.
Most obviously, the forward interest rate urve at any instant depends only
upon term, whilst forward mortality rates will exist aross a surfae of ages
and years. Mortality rates typially also inrease exponentially with age,
unlike interest rates whih are typially bounded as term inreases. More
fundamentally, the analogy between survivorship under a fore of mortality
and disounting under a fore of interest, whilst mathematially appealing,
is not exat, sine mortality will aet the atual amount of any ashow
payable (say, in an annuity or life assurane ontrat) in a way that dis-
ounting does not. We therefore do not believe that simply taking existing
models whih work well for forward interest rates and applying them diretly
to mortality rates is appropriate.
In addition, we must be able to alibrate a model of forward mortality
rates to the small number of longevity-linked seurities in existene. This
means that models whih start by assuming the existene of suient mar-
ket pries to dene a forward mortality surfae (suh as those based on the
Heath-Jarrow-Morton framework) and then dene the dynamis of this sur-
fae are not pratial. This approah is inherited from the interest rate
markets, where liquid markets in bonds aross the whole of the relevant term
struture an provide suh information. Unfortunately, this simply does not
hold for the market in longevity-linked seurities, and will not hold for the
foreseeable future.
Instead, we propose a new approah, whih is desribed in two studies,
of whih this is the rst. Our approah starts from the historial data on
the observed mortality rates, i.e., the observed fore of mortality whih is
analogous to the short rate of interest. Building on the dynamis of models
of the observed fore of mortality, we an reast them in the form of models
of forward mortality rates and then use a hange of measure to inorporate
whatever market information is available. This approah ensures that the
dynamis of the forward mortality surfae are onsistent with those observed
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for the fore of mortality, inluding features suh as ohort eets whih
are unique to mortality rate models, and whih helps to ensure demographi
signiane.
1
We begin our analysis in this paper in Setion 2.1 with models of the
fore of mortality from the age/period/ohort (APC) family, whih have
been speially onstruted in order to apture the dynamis of mortality
parsimoniously and with demographi signiane. APC mortality models
are onsidered in detail in Hunt and Blake (2015i) and enompass a broad
lass of existing and popular models of the fore of mortality, suh as the Lee-
Carter (Lee and Carter (1992)), Cairns-Blake-Dowd (Cairns et al. (2006a))
and lassi APC (Hobraft et al. (1982)) models, as well as many of the ex-
tensions of these models (see Hunt and Blake (2014) for examples). We then
develop the mathematial framework required to onvert any APC model of
the fore of mortality into a model of the forward mortality surfae in Setion
2.2 and Setion 2.3. In Setion 2.4, we use the dynamis of the period and
ohort parameters observed in the historial data to dene a forward surfae
of mortality rate. This enables onsistent modelling of both the short and
forward mortality rates, and so avoids any inonsistenies between the two.
Setion 3 then builds on this by transforming the forward mortality rate
surfae, using the Essher transform, from a measure onsistent with the
real-world proess observed in the historial data to one onsistent with
market pries. These market-onsistent forward mortality rates are then
used to prie various longevity-linked seurities. Finally, Setion 4 onludes.
The approah established in this paper is extended in our seond paper,
Hunt and Blake (2015d), whih analyses how the forward surfae of mor-
tality an be updated dynamially. This enables the forward mortality rate
framework developed in this paper to be used for managing longevity risk in
a life assurane book or in a portfolio of longevity-linked seurities.
1
Demographi signiane is dened in Hunt and Blake (2015i) as the interpretation of
the omponents of a model in terms of the underlying biologial, medial or soio-eonomi
auses of hanges in mortality rates whih generate them.
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2 Forward mortality rates in disrete time
2.1 Age/period/ohort models of the fore of mortality
In Hunt and Blake (2015i), we disussed disrete-time mortality models of
the form






t + γt−x (1)
where
• we have historial data for ages, x, in the range [1, X ] and periods, t,
in the range [1, τ ] and therefore observations of ohorts born in years,
y, in the range [1−X, τ − 1];
• ηx,t = ln(µx,t) is the log-link funtion whih onnets the Poisson dis-
tributed death ounts, Dx,t, to the proposed preditor struture;
• αx is a stati funtion of age;
• κ(i)t are period funtions governing the evolution of mortality with time;
• β(i)x are age funtions modulating the impat of the period funtion
dynamis over the age range;
2
and
• γy is a ohort funtion desribing mortality eets whih depend upon

















, we an re-
write Equation 1 as
ηx,t = αx + β
⊤
xκt + γt−x (2)
In this paper, we will use the log-link funtion ηx,t = ln(µx,t). In Hunt
and Blake (2015i), we disussed how this is appropriate if the death ount
2
These an be non-parametri in the sense of being one tted without imposing any a
priori shape for the funtion aross ages, or be parametri in the sense of having a spei
funtional form, β
(i)
x = f (i)(x; θ(i)) seleted a priori. Potentially, parametri age funtions
an have free parameters θ(i) whih are set with referene to the data.
5
at age x and time t is a (onditionally independent) Poisson random vari-
able, Dx,t ∼ Po(µx,tEcx,t), where Ecx,t are entral exposures to risk. This is
preferred over the alternative hoie of the logit-link funtion and binomially
distributed death ounts due to the distributional properties of the forward
mortality rates, as disussed in Setion 2.3.
This struture denes the lass of age/period/ohort (APC) mortality
models and is very exible. Many of the most ommon mortality models t
into this struture, for instane, the benhmark Lee-Carter (LC) model of
Lee and Carter (1992), the ohort extension to this denoted H1 in Haberman
and Renshaw (2009), the Cairns-Blake-Dowd (CBD) model of Cairns et al.
(2006a) and many of its extensions in Cairns et al. (2009), the Plat model
of Plat (2009) and the model of Börger et al. (2013). In Hunt and Blake
(2014), we desribe a general proedure for onstruting bespoke models
within this lass whih are tailored to the struture within a given dataset.
3
It is, therefore, appropriate to use this lass of models of the fore of mortality
as the starting point for dening the forward mortality surfae, as disussed
below.
2.2 Dening forward mortality rates
In a disrete-time framework, the fore of mortality, µx,t, at age x and time
t is assumed to be onstant over eah age and year, i.e.,
µx+ξ,t+τ = µx,t (3)
x, t ∈ N
ξ, τ ∈ [0, 1)
Therefore, the one-year survival probability from age x at time t to age x+1
at time t + 1, px,t,
4
is equal to px,t = exp(−µx,t). If we further assume that
3
The forward mortality framework desribed in this study is not signiantly aeted if
the ohort parameters are modulated by an age funtion, β
(0)
x , as in the model of Renshaw
and Haberman (2006). However, for simpliity and the reasons disussed in Hunt and
Blake (2015i), we do not onsider suh models in this study.
4px,t = 1− qx,t, the one-year probability of death.
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where tpx,τ is the survival probability of an individual from age x at time τ
to age x+ t at time τ + t.5 If τ + t lies in the future, tpx,τ will be a random
variable, as future values of the fore of mortality will be subjet to system-
ati mortality risk.
To dene the struture of forward mortality rates, we assume that the fun-
damental longevity-linked seurity
6
of interest, from whih all other longevity-
linked seurities an be onstruted, is the longevity zero.
7
A longevity
zero is dened in Blake et al. (2006) as a zero-oupon bond whih pays out a
prinipal at a future time, dependent on the survivorship of a suitably large
ohort (to redue the idiosynrati risk in the estimation of survival rates)
over the term of the bond.
8
Therefore, a t-year longevity zero at time τ
would have prie
Prie(t, τ) = B(τ, τ + t)EQτ tpx,τ
where B(τ, τ + t) is the time τ prie of a t-year zero oupon bond paying one
unit at maturity, and where the expetation is dened under some market-
onsistent measure, Q (to be disussed in Setion 3).9
In doing so, we have impliitly assumed that the longevity risk is inde-
pendent of the other nanial risks in the market, suh as interest rates and
5
0px,τ = 1 trivially.
6
In this paper, we use the term seurity to refer to any tradable nanial ontrat,
and so also inlude derivative seurities suh as forwards and options in this denition.
7
Longevity zeros were also used to dene forward mortality rates in Barbarin (2008)
for use in a Heath-Jarrow-Morton framework and in Cairns (2007) and Alai et al. (2013)
to develop extensions of the Olivier-Smith model.
8
It is important that the seurity used to dene the forward mortality rates depends
purely on the systemati omponent of longevity risk, rather than on the idiosynrati time
of death of any individual lives, in order to avoid the potential for oniting denitions
of the forward rates desribed in Norberg (2010).
9
We adopt the onvention that the subsript on operators Eτ (.), Varτ (.) or Covτ (.)
denotes onditioning on the information available at time τ , i.e., Fτ .
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ination, in both the real-world measure, P, and the market-onsistent mea-
sure, Q. This is in ommon with the majority of studies, suh as Cairns
et al. (2006b) and Bauer et al. (2008) and with the available evidene to
date, as disussed in Loeys et al. (2007). Although there may be some situ-
ations where longevity risk is not independent of other nanial risks in the
real-world measure, as in the examples of Miltersen and Persson (2005), we
believe that these situations are relatively extreme and are better onsidered
by senario analysis rather than through a stohasti model. Furthermore,
Dhaene et al. (2013) show that independene between longevity risk and
nanial risks in the real-world measure does not automatially ensure in-
dependene in the market-onsistent measure. However, more ompliated
models are required in order to allow for any dependene between longevity
and investment risks, whih require more market information for alibration.
Therefore, we believe that the assumption of independene between longevity
risk and other nanial risks is neessary and justiable at this early stage

















x,τ(τ) are the market-onsistent forward survival probabilities,
i.e., the market's best view (in the words of Miltersen and Persson (2005))
at τ of the probability of an individual aged x at τ surviving a further t years.
Mathematially, we an see that these fators are analogous to disount fa-
tors based on the pries of zero-oupon bonds. It is this analogy whih has
motivated muh of the development of forward mortality rate models to date,
whih have been mainly adapted from widely used interest rate models. In
ontinuous-time forward rate models, suh as in Bauer et al. (2008), forward










via the analogy with forward interest rates. In a disrete time model, we
8
modify this to dene forward mortality rates as










Existing forward mortality models, suh as those in Cairns (2007) and
Zhu and Bauer (2011b, 2014) use similar denitions, but these studies are
interested in the dynamis of the forward surfae of mortality and so are
interested in the behaviour of νx,t(τ + 1)/νx,t(τ) , rather than the forward
mortality rates at τ themselves (whih are assumed a priori in these studies).
We disuss these dynamis in Hunt and Blake (2015d). In ontrast, this paper
is interested in the onnetion between the fore of mortality and forward






























whih shows the onnetion between the market-onsistent forward rates and



















In pratie, the variation in µx,t is suiently small that Equation 9 holds
approximately as an equality over almost all ages and years.
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We therefore



















This approximation is tested numerially in Appendix B.
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Thus, the forward mortality rate at age x and year t is assumed to be equal
to the expetation under the market-onsistent measure of the fore of mor-
tality at the same age and year, onditional on information observed at time
τ . Thus, if we an speify the dynamis of the fore of mortality (in the
market-onsistent measure), we are able to nd the forward mortality rates
diretly.
We dene the forward mortality surfae as the olletion of forward
mortality rates, νQx,t(τ) over all ages, x, and future years, t, at a given point
in time, τ . In most ases, it is more natural to onsider the forward mortal-
ity surfae as a single objet, sine the individual forward mortality rates are
expeted to vary smoothly aross ages and aross future years. However, it is
important to realise that the forward mortality surfae is three-dimensional,
dened by x, t and τ . In this paper we shall onsider its struture aross the
dimensions of x and t and how this an be determined at the observation
time, τ , whih is assumed to be xed. This ontrasts with Hunt and Blake
(2015d), where we disuss how the surfae varies dynamially with τ .
In dening the forward mortality surfae, we assume that all longevity-
linked seurities an be onstruted from a portfolio of longevity zeros. We
shall see in Setion 3.3 that this is trivially true in the ase of longevity
swaps.
11
We extend this by assuming that the value of any other longevity-
linked seurity at time τ an be repliated as a portfolio of longevity zeros
and, therefore, written as a funtion of the νQx,t(τ). Hene, the forward sur-
fae of mortality an be used to give onsistent pries for all longevity-linked
liabilities and seurities.
Unfortunately, however, it is urrently impossible to reliably speify the
dynamis of short or forward mortality rates in the market-onsistent mea-
sure, sine an atively-traded market in longevity-linked seurities does not
urrently exist. Indeed, the absene of genuine market information on the
pries for any longevity-linked seurities is a ritial problem for all studies
11
It is also true for the valuation of annuities for reserving purposes, sine idiosynrati
risk is not allowed for in this ontext.
10
that seek to value the few longevity-linked seurities whih do exist. There
have been a number of dierent methods proposed to overome this and
alibrate the market-onsistent measure. For instane, Bauer et al. (2008)
proposed using generational life tables (i.e., those whih allow mortality rates
to depend upon an individual's year of birth) in order to provide a forward
mortality surfae. However, these are updated infrequently and are not based
on market information (and when used to prie nanial ontrats, typially
have margins for risk aversion added to them). Alternatively, Miltersen and
Persson (2005) and Bayraktar and Young (2007) have suggested using the
market for endowment assuranes for alibration purposes, sine these have
a similar prie struture to longevity zeros. Unfortunately, Norberg (2010)
showed how using seurities dependent on the idiosynrati risk of individual
lives, suh as endowment assuranes, an lead to inonsistent denitions of
the forward mortality rates and so this approah is not feasible.
Instead, we propose to use the historial data to model the dynamis of
the fore of mortality in the historial or real-world measure, P, using
relatively simple APC mortality models, as desribed in Setion 2.1. These
real-world dynamis of the fore of mortality an then be used to generate the
forward surfae of mortality in the real-world measure by using Equation 11.
Then, in Setion 3.1, we show how to hange from the real-world to a market-
onsistent measure, Q, using the Essher transform whih is alibrated using
whatever (limited) market information for longevity risk is available. Thus,
real-world data on historial mortality rates is used to supplement the limited
market data we have, and inreasing volumes of market information an be
inorporated into the forward mortality surfae as the market for longevity-
linked seurities develops.
2.3 Forward APC mortality models
Combining Equations 2 and 11, we dene forward mortality rates in the










We assume that the age funtions are known with ertainty at time τ and
therefore the unertainty in future mortality rates omes from the projetion
of κt andγt−x, i.e., the forward mortality surfae only allows for proess risk
11
from the projetion of the period and ohort funtions, in the terminology
of Cairns (2000), but not parameter unertainty or model risk. In the real-
world measure, we rst obtain tted values of κt and γy by tting the APC
model to the historial data. We then estimate the dynamis of the time
series proesses for κt and γy from these tted values.
If we further assume that our projeted κt and γy are normally dis-























The assumption that projeted period and ohort parameters are nor-
mally distributed is in line with the majority of studies, whih use standard
ARIMA methods to projet these parameters. If the projeted period and o-
hort parameters are not normally distributed, however, it is unlikely that the
resulting forward mortality framework would be analytially tratable. This
is beause the distribution of µx,t would not have the nite moments required.
A number of studies have used alternative methods and distributions to make
projetions. These inlude models whih allow for regime hanges (Milidonis
et al. (2011) and Lemoine (2014)) or trend hanges (Sweeting (2011) and
Hunt and Blake (2015)) in the proesses used to projet the parameters.
Another approah has been to use other distributions for the innovations in
the time series proesses for the period or ohort funtions (suh as the t-
distribution, the variane-gamma and the normal-inverse-gamma, whih were
used to model the innovations for κt in the Lee-Carter model in Wang et al.
(2011)). In some of these ases, it may be possible to extend the forward
mortality rate framework to allow for the non-Gaussian distributions. How-
ever, we do not onsider alternative distributions for the projeted period or
ohort funtions further within this study.
12
Note that, if we were using ηx,t = logit(qx,t) in onjuntion with a binomial model for
the death ount, then qx,t would follow a logit-normal distribution (see Frederi and Lad
(2008)). Unfortunately, this is not analytially tratable and does not possess losed form
expressions for the expetation. Therefore, we are unable to dene a forward mortality
framework in the logit-link funtion / binomial death ount model as we an in the log-link
funtion / Poisson death ount model.
12
2.4 Projeting the APC model
2.4.1 Period funtions
Sine Lee and Carter (1992), the most ommon method used to projet
the period funtions in an APC mortality model has been the random walk
with drift. This was also used for the CBD model in Cairns et al. (2006a),
the period funtions in various mortality models in Cairns et al. (2011) and
Haberman and Renshaw (2011), and the rst (dominant) period funtion in
Plat (2009).
The random walk model is attrative as it allows the period funtions to
be non-stationary with a variability that inreases with time, giving biologi-
ally reasonable
13
projetions of the fore of mortality.
In Hunt and Blake (2015f,g), we disuss how projeted mortality rates
should not depend upon the identiability onstraints used when tting the
model to data, and therefore that we should use well-identied projetion
methods whih ahieve this. In the ontext of the random walk with drift
model, this means we should projet the period funtions using
κt = µXt + κt−1 + ǫt (14)
where Xt is a set of deterministi funtions (trends) hosen to ensure iden-
tiability and µ are the orresponding drifts.14 For example, the lassi
random walk with drift proess has a onstant trend, Xt = 1, with the
drift, µ, found be regressing ∆κt on this trend. Similarly, the random walk
with linear drift introdued in Hunt and Blake (2015g) and Hunt and Blake




, with the drifts found
by regressing ∆κt against Xt in a similar fashion.
13
Introdued in Cairns et al. (2006b) and dened as a method of reasoning used to
establish a ausal assoiation (or relationship) between two fators that is onsistent with
existing medial knowledge.
14
Note, we assume that the drifts µ are known at time τ and will not be re-estimated
on the basis of new information arising in the future. Therefore, the forward mortality
framework desribed in this paper and in Hunt and Blake (2015d) does not allow for
realibration risk as dened in Cairns (2013), i.e., the risk aused by the unertainty in
the drift. This risk is potentially substantial, as disussed in Li et al. (2004) and Li (2014).
However, we leave the inlusion of realibration risk to future work.
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The random drift model in Equation 14 is solved to give







s=τ+1Xs. Note that, in the simplest ase where we use a
lassi random walk with drift to projet the period funtions, Xt = 1 and
hene χτ,t = t− τ . We assume
Eτǫt = 0
Covτ (ǫt, ǫs) = ΣIt−s
where It−s is an indiator variable taking a value of unity if t = s and zero
otherwise. This means that the innovations have zero mean and are inde-
pendent aross dierent periods, i.e., they are white noise. In addition, we
assume that the innovations are normally distributed for the reasons dis-
ussed above. From Equation 15, we nd
EPτ κt = κτ + µχτ,t (16)
VarPτ (κt) = (t− τ)Σ (17)
In an age/period mortality model without a ohort term, suh as the Lee-
Carter or CBD model, allowing for the unertainty in the period funtions is
suient in onjuntion with Equation 13, to dene forward mortality rates
in the real-world measure. However, more sophistiated mortality models
often inlude ohort terms, whose analysis is onsiderably more ompliated,
as we now see.
2.4.2 Cohort funtion
Most ommon tehniques for projeting the ohort funtion use standard
ARIMA proesses, whih assume that there is a lear distintion between
those ohort parameters whih are estimated from historial data, whih are
assumed to be known, and those ohort parameters whih are projeted us-
ing some time series proess. In the forward mortality rate framework, we
an see that this would lead to a sharp disontinuity in the forward mortality
surfae. For many purposes, suh as the valuation of longevity-linked seu-
rities and liabilities, suh a disontinuity is learly undesirable.
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To illustrate this problem, onsider the ase where a (well-identied)
AR(1) proess is used to projet the ohort parameters
γy − βX̃y = ρ(γy−1 − βX̃y−1) + εy
where X̃y are deterministi funtions orresponding to the unidentiable
trends in the ohort parameters,
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and β are the orresponding regression
oeients (see Hunt and Blake (2015g)). Suh a proess would be solved to
give
γy = ρ





for y ≥ Y , the year of birth of the last tted ohort parameter.16 The
variane of this proess is
VarPτ (γy) =
{
0 if y ≤ Y
1−ρ2(y−Y )
1−ρ2
σ2 if y > Y
From Equation 13, we see that this would give a disontinuity in the forward
mortality surfae at the interfae between the tted and projeted ohort
parameters. Suh a disontinuity would give rise to priing anomalies and
therefore annot be permitted in a well-designed forward mortality frame-
work. Consequently, we must use alternative proesses to projet the ohort
parameters for use with forward mortality models.
In Hunt and Blake (2015a), we developed a Bayesian approah to over-
ome this issue. This assumes that all ohort parameters, γy, are random
variables that are not fully observed until ohort y is fully extint at time
y +X . For observation times τ < y +X, we have partial information based
on observations of the ohort to date. This information is summarised in
the estimated ohort parameters, γy(τ), found by tting the APC mortality
model to data to time τ . From the analysis in Hunt and Blake (2015a), we
have
γy|Fτ ∼ N(M(y, τ), V (y, τ)) (18)
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In general, these have a similar form to the deterministi funtions for the period
parameters, Xt, in Setion 2.4.1.
16
Typially, ohort parameters for the last few years of birth are not estimated due to
















Dτ−yγy(τ) + (1−Dτ−y+s)β(X̃y−s − ρX̃y−s−1)
]
(20)








for y ≤ Y , where





V (y, τ) =
1− ρ2(y−Y )
1− ρ2 σ
2 + ρ2(y−Y )V (Y, τ) (23)
for y > Y . In this,
• Dx is the proportion of a ohort assumed to still be alive by age x;
• ρ and σ2 are the autoorrelation and variane of the AR(1) proess
assumed to be driving the evolution of the ohort parameters;
• X̃y and β are the trends and drifts for the ohort parameters as dened
above;
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• γy(τ) are the estimates of the ohort parameters, tted by the mortality
model at time τ ; and
• Fτ is the total information available at time τ , inluding observations
of the ohort parameters up to year of birth y, i.e., {γυ(τ) υ ≤ y}.
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Note that the drifts, β, depend upon the arbitrary identiability onstraints hosen.
In pratie, we therefore impose a set of identiability onstraints suh that β = 0 to
simplify matters onsiderably.
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In Hunt and Blake (2015a), it was shown that this framework allows the
historial and projeted ohort parameters to be treated onsistently, without
any sharp disontinuities in the unertainty between them. It was also shown
that these projetions are well-identied, in the sense that they do not depend
upon the arbitrary identiability onstraints made when tting the model. In
addition, it is shown in Hunt and Blake (2015d) that the Bayesian framework
allows us to update estimates of the ohort parameters over a one-year period
to proxy for the impat that new data would have on our parameter estimates,
whih is essential for risk management purposes. The Bayesian framework
is therefore well adapted for use in a forward mortality ontext, and we will
use it for all APC mortality models whih inlude ohort parameters.
2.5 Estimation and projetion
The framework desribed in Setions 2.3 and 2.4 is very general and an be
used in onjuntion with any APC mortality model for the fore of mortality.
To see this in pratie, we onsider estimating the forward mortality rates on
male data for the UK for the period 1950 to 2011 and ages 50 to 100 from
the Human Mortality Database (2014) for ve dierent APC models:
1. the Lee-Carter (LC) model of Lee and Carter (1992);
2. the CBDX model disussed in Hunt and Blake (2015f), whih extends
the Cairns-Blake-Dowd model of Cairns et al. (2006a) with a stati age
funtion and uses a log-link funtion;
3. the lassi APC model of Hobraft et al. (1982) and others;




5. the model produed by the general proedure (GP) in Hunt and
Blake (2015b) for the data desribed above.
18
That is, the simpliation of the main model disussed in Plat (2009) without the
third, high-age term or, equivalently, an extension of the CBDX model with a ohort
term.
17





































The parameters in these models have been estimated by tting the model
to the UK population data desribed above. These tted parameters have,
in turn, been used to estimate the parameters of the time series proesses
disussed in Setions 2.4.1 and 2.4.2 for κt and γy (if appliable). Using these
parameter estimates, we an alulate forward mortality rate surfaes in the
real-world measure using Equation 12.
These models have been hosen to give a reasonable ross setion of the
dierent APC mortality models whih ould be used in pratie. One of the
advantages of the forward mortality rate framework desribed in this paper
is that it allows for onsisteny between the model of the fore of mortality
and the forward mortality surfae. Consequently, as a hek, we ompare
these forward surfaes of mortality for eah model to the mean mortality
rates alulated using Monte Carlo simulations (shown in Figure 1 for the
GP model) and nd that the small dierene between the two is explained
by sampling error in the simulations.
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See Hunt and Blake (2015b) for full details of the onstrution of the GP model. For all




x |f(x)| = 1.
This involves either inluding normalisation onstants or hoosing age funtions whih are
self-normalising in the sense of Hunt and Blake (2015f). However, for larity, these are
not shown, although they are taken into aount in the tting algorithms.
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Figure 1: Dierene between forward mortality rates and those obtained
from Monte Carlo simulations using the GP model
3 Priing seurities and the market prie of
longevity risk
3.1 The market-onsistent measure
In Setion 2.4, we alulated mortality forward rates using the time series
proesses estimated from the tted parameters. This means that the expe-
tations in Equation 13 were alulated in the historial, real-world measure,
P.
It is obviously important that longevity-linked seurities pries are on-
sistent aross dierent types of seurity in order to limit the potential for
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priing anomalies and arbitrage opportunities in the market. In addition,
modern solveny regimes require that liability values and tehnial provi-
sions for pension shemes and insurers must also be onsistent with market
pries. Identifying a suitable market-onsistent measure, Q, is therefore a
ritial omponent of the forward mortality framework.
The starting point of modern nanial theory is to assume that the -
nanial markets are omplete in the sense that every nanial laim in
them an be hedged perfetly using tradable assets. In omplete markets,
the market-onsistent measure exists and is unique. Derivative seurities in
omplete markets an be perfetly repliated using these underlying seurities
without risk (and hene these measures are also referred to as risk-neutral)
and the osts of these hedging strategies give the derivatives their unique
pries. Complete markets are also free from arbitrage, sine all pries an
be derived using these underlying hedging strategies and any deviation from
these pries will be arbitraged away by informed investors. The assumption
of market ompleteness is a reasonable one in many ontexts, suh as devel-
oped markets for equities and interest rates in large and advaned eonomies.
However, the market for longevity risk is not omplete. Not only are there
insuient tradable longevity-linked seurities to fully repliate all nanial
laims, there are almost no longevity-linked seurities being atively traded,
full stop. Therefore, dening a market-onsistent measure for longevity risk
is a major problem for all mortality models whih seek to prie longevity-
linked seurities.
Some studies, for instane Shrager (2006), assume a priori that any mar-
ket will be risk-neutral with respet to longevity risk and therefore that the
historial and market-onsistent measures are equal. We believe this is un-
likely, given that any market in longevity risk is likely to be dominated by
parties that suer nanially from rising life expetany (see Loeys et al.
(2007)) and therefore will be generally seeking to hedge the risk of future
improvements in mortality rates.
In light of this absene of information, Barrieu et al. (2012, p. 224)
suggested that the real-world measure must play a key role in the denition
of any market-onsistent measure:
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What will be a good priing measure for longevity? It is expeted
that the historial probability measure will play a key role, due
to the reliable data assoiated with it. Therefore, it seems nat-
ural to look for a priing probability measure equivalent to the
historial probability measure. Important fators to onsider are
that a relevant priing measure must be: robust with respet to
the statistial data, and also ompatible with the pries of the
liquid assets quoted in the market. Therefore, a relevant proba-
bility measure should make the link between the historial vision
and the market vision. One the subsets of all suh probability
measures that apture the desired information are speied, a
searh an ommene for the optimal example by maximising the
likelihood or the entropi riterion.
We agree with this analysis, and use the Essher transform to dene a
market-onsistent measure that is equivalent to the real-world measure and
that satises many of these desirable properties. This transformation is rel-
atively parsimonious, with a small number of free parameters whih an be
alibrated using any market information we possess. Below, we further show
that the Essher transform gives us losed form expressions for the market-
onsistent forward mortality rates as shown below, and therefore is relatively
straightforward to implement and robust to alibrate to data.
The Essher transform has often been used in seurities priing in im-
perfet markets sine the work of Gerber and Shiu (1994). As disussed
in Kijima (2005), it is related to other widely used distortion methods for
adjusting to a risk-neutral measure, suh as the the Wang transform (devel-
oped in Wang (2000, 2002) and Cox et al. (2006), and used in Denuit et al.
(2007) for example), and the Sharpe ratio in modern nanial theory (used
in Milevsky et al. (2005) and Loeys et al. (2007)). It is also onsistent with
priing in the real-world measure for an individual with an exponential util-
ity funtion, as disussed in Milidonis et al. (2011).
For a risk Xx,t in the P measure, the general Essher transform to the Q






where Zx,t is a random variable ontaining the parameters dening the market-
onsistent measure.
In the ontext of mortality forward rates, we hoose Xx,t = µx,t =




where λ is an (N × 1) olumn vetor. Hene, there are N + 1 parameters
(whih we refer to olletively as λ(j), j ∈ {1, . . . N, γ}), whih orrespond to
the N age/period terms (in the vetor λ), and the ohort term (with single
parameter λ(γ)) in the general APC mortality model in Equation 2. It is im-
portant to note that the values found for these parameters will depend upon
the speis of the underlying model, and so are not omparable between
dierent models.
Due to the pauity of genuine market information to prie longevity risk,
one might have a natural inlination to prefer simpler models, suh as the LC
model (whih has only one free parameter for the Essher transform). Suh
models ould be felt to be more parsimonious, having fewer market pries
for longevity risk and therefore requiring fewer market pries for longevity-
linked seurities in order to alibrate the market-onsistent measure. For
example, alibrating the LC model would require only one market prie in
order to alibrate the market-onsistent measure, whilst alibrating the GP
model in Setion 2.5 requires four market pries. Using overly simple models,
however, would be a mistake whih an lead to unreasonable pries for other
longevity-linked seurities as shown in Setion 3.3.











EPτ exp(αx + (βx − λ)⊤ κt + (1− λγ)γt−x)






























−β⊤xVarPτ (κt)λ− λγVarPτ (γt−x)
)
νPx,t(τ) (31)
due to the symmetry of VarPτ (κt).
This gives us losed-form expressions whih allow us to adjust the forward
mortality rates in the real-world measure to a market-onsistent measure.
The existene of losed-form expressions is why we argued that the Essher
transform neatly omplements the forward mortality framework: these re-
sults ould not have been ahieved with alternative transformations to the
market-onsistent measure. Sine we have already found expressions for
VarPτ (κt) and Var
P
τ (γy), transforming the forward mortality surfae in the
real-world measure into a market-onsistent measure is simply a matter of
nding the values of free parameters of the Essher transform. This an be
done if we have suient pries for longevity-linked seurities, as disussed
in Setion 3.2 below.
Through the analogy with utility priing and the Sharpe ratio, we refer
to the parameters of the Essher transform as the market pries of longevity
risk assoiated with eah of the age/period and ohort terms. For this anal-
ogy to be reasonable, we would antiipate that the parameters, λ(j), should
be positive. However, this is not neessarily the ase in the forward mortality
framework, for the following reasons.
As disussed in Loeys et al. (2007), we antiipate that the marginal par-
tiipant in the market for longevity-linked seurities will be a life insurer
23
seeking to hedge longevity risk. Suh a life insurer will be averse to longevity
risk, and so, we would expet the market-onsistent forward mortality rates
to be lower than those in the real-world measure
νQx,t(τ) ≤ νPx,t(τ)
In order for this to be true,
exp
(
−β⊤xVarPτ (κt)λ− λγVarPτ (γt−x)
)
≤ 1
⇒ β⊤xVarPτ (κt)λ+ λγVarPτ (γt−x) ≥ 0
Sine VarPτ (κt) is a positive denite matrix and Var
P
τ (γy) ≥ 0, this will er-
tainly be true if λγ > 0 and the elements of λ are also positive. However,
individual market pries of longevity risk an be negative, whilst still ensuring
that hedgers pay a positive prie to transfer longevity risk overall. Sine some
market pries an be negative, the term market pries might be onsidered
misleading. Although we shall refer to these parameters as market pries in
this paper and in Hunt and Blake (2015d), it should be borne in mind that
they are probably best thought of as simply parameters in the Essher trans-
form in Equation 29 rather than true market pries of longevity risk based
on an expeted utility approah (suh as that disussed in Zhou et al. (2015)).
The Essher transform approah has some other pratial advantages, be-
yond the existene of losed-form expressions for the forward mortality rates.
The forward mortality surfae in the real-world measure will be updated only
infrequently, typially one every year when new mortality data is released.
However, market information will need to be updated far more frequently, es-
peially as the market for longevity-linked seurities develops. It is desirable
in pratie to be able to take the (infrequently hanging) P-measure forward
mortality surfae and make relatively simple adjustments to this to reet
hanging market information, rather than having to re-estimate the model
ompletely every time the priing information hanges.
However, a limitation of the forward mortality framework outlined in this
study is that it is urrently unable to prie longevity-linked seurities with
optionality, for example, a all option on mortality rates. In order to do this,
the dynamis of mortality rates in the market-onsistent measure would need
to be speied, in addition to simply the expetation, EQτ µx,t. We leave the
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extension of the forward mortality framework to the inlusion of longevity-
linked options to future work.






xVarτ (κt)λ = β
⊤
x [κτ + µχτ,t + (t− τ)Σλ]
= β⊤x [κτ + µ̂χτ,t]
sine t − τ is always one of the deterministi funtions in χτ,t. Hene, we
see that for an age/period model suh as the LC and CBDX models, the
Essher transform to the market-onsistent measure is equivalent to making
an adjustment to the drift of the random walk in Equation 14. This approah
is developed further in Hunt and Blake (2015e). In this form, the use of the
Essher transform an be ompared with some of the other approahes that
have been suggested in previous studies. For instane, Loeys et al. (2007)
suggested that the prie of a q-forward should be alulated as
qf = (1− (t− τ)λ̃σ2)qe
where σ2 is dened as the annual volatility of the mortality rate, i.e., σ2 =
VarP(ln q). We an ompare this priing formula to what our forward mor-
tality framework would give were we to use the LC model as the underlying
mortality model. This has one period funtion, κt, with one assoiated mar-
ket prie of risk, λ. From Equation 31 applied to the LC model, we nd
νQx,t(τ) = exp (−(t− τ)βxΣλ) νPx,t(τ)
We an therefore see that the priing formula in Loeys et al. (2007) is similar
in form to Equation 31, although based on forward ontrats on probabilities
of death, qx,t, rather than the longevity-zeros whih are used as the underly-
ing seurities in this study.
Cairns et al. (2006a) adjusted the drift of the random walk used to
projet the period funtions diretly, in order to inorporate market pries
for longevity risk without reourse to the Essher transform
µQ = µP − Cλ̃
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where CC⊤ = Σ and λ is a vetor of the market pries of risk. If suh an
approah were to be used for the CBDX model in a forward mortality rates







Therefore, we see that the approah used in Cairns et al. (2006a) is equiv-




Hene, the more rigorous forward mortality framework dened in this study
ahieves results whih are onsistent with those of Cairns et al. (2006a), but
is also able to justify the otherwise ad ho adjustments to the drift made in
that study.
3.2 Calibration of the market-onsistent measure
As has been mentioned previously, a major problem with forward mortality
models is the lak of market information to speify the market-onsistent
measure. An advantage of using the forward mortality framework desribed
in this study is that, rather than requiring suient market pries to dene
the full forward mortality surfae, we require only N + 1 pries to uniquely
speify the market pries of longevity risk used in the Essher transform.
This substantially redues the market information required.
However, even this simpliation is unlikely to be adequate at present,
given the pauity of traded longevity-linked seurities. Many of those whih
do exist, suh as the extreme mortality bonds listed in Lane (2011), are not
suitable as they involve options on mortality rates whih annot be pried
using the forward mortality framework as proposed here.
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For illustrative
purposes, we will demonstrate how the forward mortality rate framework
ould be alibrated with respet to the sort of information whih is available
20
We extend the forward mortality framework to allow for the valuation of longevity-
linked options in Hunt and Blake (2015e).
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urrently or is likely to be available in the foreseeable future, and how this
external market in longevity risk ould be supplemented by use of an in-
ternal market for longevity risk based on the assumptions used to value and
reserve for longevity risk within a life insurer.
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3.2.1 External market
A number of external markets exist for produts whih depend upon longevity,
for instane the markets for endowment assuranes and individual annuities.
These were used to provide market information for priing longevity risk in
Bayraktar and Young (2007) and Bauer et al. (2008). However, both of these
produts are sold to individuals, and therefore are subjet to idiosynrati
mortality risk as well as systemati longevity risk, whih makes them unsuit-
able for use in a forward mortality rate framework, as disussed by Norberg
(2010). Furthermore, insurers will inlude loadings for expenses and other
risks, in addition to longevity risk when priing these produts, whih makes
using them to alibrate a forward mortality model problemati.
Instead, any forward mortality model will need to be alibrated using
seurities dependent on aggregate mortality rates (preferably from national
populations) rather than those that are sold to individuals. Suh seurities
are also more likely to be traded, thereby giving informed and responsive
market pries. The problem remains, however, that there is urrently no
atively-traded market in suh seurities whih an be used to provide the
priing information required to alibrate the market-onsistent measure.
To date, probably the most ative market in longevity-linked seurities
has been that for bespoke longevity swaps (see Hunt and Blake (2015k)).
A longevity swap is an agreement between two parties to swap a series of
ashows - a xed leg based on the best estimate of the survivorship of a
ohort but then inreased by a onstant perentage (the swap margin) and
a oating leg based on the atual survivorship observed for the ohort. A
bespoke longevity swap is one whih is tailored to the harateristis of a spe-
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In a sense, the dierene between the external and internal markets for longevity risk
ould be ompared to the dierene between using mark-to-market and mark-to-model
valuation methods when valuing seurities in ompany aounts, depending upon whether
deep and liquid markets exist for them.
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i population suh as a pension sheme. As suh, bespoke longevity swaps
are unlikely to be widely traded, and at more as ustomised reinsurane
ontrats than standardised longevity-linked seurities whih ould form the
basis for a market in longevity risk. In ontrast, an index-based swap, suh
as that desribed in Dowd et al. (2006), is one where the ohort in question
is from a national population. Although index-based longevity swaps have
not yet been widely traded, the development of the bespoke longevity swap
market to date implies that, if a market in longevity risk does develop in the
near future, it is likely that index-based swaps will form a key omponent of
it.
For illustrative purposes, we therefore assume the existene of a single
index-based longevity swap, whih we believe might be typial of the sort
of seurity whih may be traded during the early stages of the development
of an external market in longevity-linked seurities. We assume that this
index-based longevity swap has been written on a standard ohort of men in
the UK aged 65 in 2011 and has a term of 35 years (i.e., until the ohort is






65,τ (τ)B(τ, τ + t)
i.e., the same prie as a series of the longevity zeros disussed in Setion 2.2.
The xed-leg ashows will reet a typial best estimate agreed between
the ontrating parties when the swap is initiated. For illustrative purposes,
we assume these ashows are set by alulating the survivorship of the ref-
erene ohort using the tted mortality rates in τ = 2011 projeted using
the CMI Projetion Model (Continuous Mortality Investigation (2009a,b,
2013)) with a long-term rate of improvement assumption of 1.5% p.a..
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We
denote the survival probabilities of the referene ohort from time τ to τ + t
using this assumption as tP̃65,τ (τ). While there is urrently no ative market
in index-based swaps, this assumption is typial of those used to dene the
xed leg of bespoke longevity swaps in our experiene. These ashows are
then inreased by a swap premium of 4%, whih is a typial level on bespoke
22
The use of the CMI Projetion Model in this ontext is purely illustrative and should
not imply that we believe that this is the best model to use for priing longevity-linked
seurities, although it is typial of what has been used in pratie in our experiene.
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swaps in our experiene.







65,τ (τ)− 1.04 tP̃65,τ (τ)
)
B(τ, τ + t) (32)
and will be zero at time τ . We therefore alibrate the market pries of risk
to impose this using standard numerial optimisation algorithms. In these
alulations, we assume a at real yield of 1.0% p.a. for the zero-oupon
bond pries, B(τ, τ + t)
For models with only one soure of risk (for instane, the LC model),
this single, external prie is suient to speify the single market prie of
longevity risk uniquely. For more ompliated models, with multiple risk
soures, we require additional pries in order to speify the market pries of
longevity risk.
3.2.2 Internal market
We observe that, while genuine market information is in sare supply, many
insurane ompanies will eetively have an internal market for longevity risk
due to the ross-subsidies between dierent lines of business with dierent
exposures to longevity risk. For instane, an insurer whih writes both annu-
ity and life assurane lines of business has, de fato, established an internal
market for longevity risk due to the presene of natural hedging between the
two lines of business, as disussed in Cox and Lin (2007). The prie of
longevity risk in this internal market will nd expression in the mortality im-
provement assumptions used in the priing and reserving for these dierent
lines of business. It is therefore natural to use these internal market signals
to supplement those oming from the genuine external market if there are
insuient traded longevity-linked seurities to dene the market-onsistent
measure.
Alternatively, an insurer may develop an internal prie for longevity risk
by analysing the ost of longevity reinsurane via bespoke longevity swaps.
Although these ontrats do not solely transfer longevity risk - they also
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transfer basis and idiosynrati risks - they ould still give some indiation of
a prie for the systemati longevity risk present, and so be used to alibrate
the market-onsistent measure.
For example, we assume that the forward mortality framework is being
used by an organisation with an internal, deterministi assumption that on-
stitutes their house view of mortality improvements. This house view would
then feed through into the assumptions used in priing and reserving, and
inform those assumptions that are used for aounting and regulatory pur-
poses if there is suient exibility in how these are set. The existene of
suh a house view would therefore determine the organisation's appetite for
longevity risk aross multiple lines of business and so underpin the internal
market for longevity risk.
To illustrate the sort of internal market that might be onsidered typial,
we assume a house view that mortality rates improve in line with the proje-
tions from the CMI Projetion Model with a long-term rate of improvement
of 1.75%.
23
Again, this is in line with the sort of assumptions used to reserve
for and prie annuity business in the UK in our experiene. In order to trans-
late this house view into the market pries of longevity risk in our forward
mortality framework, we try to minimise the (weighted) relative distane be-
tween the surfae of probabilities of dying given by the internal assumption,
q̃x,t, and those given the forward mortality surfae in the Q-measure




at ertain key ages, subjet to the swap also being pried fairly at time, τ ,
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This value of 1.75% an be ompared with the assumption of a long-term rate of
improvement of 1.5% used for the xed leg of the index-based longevity swap above.
The long term rate of improvement is likely to be higher on an annuity reserving basis
than for valuing a longevity swap, sine it is ommon pratie, in our experienes, for
annuity providers to inlude an impliit margin for prudene in their mortality projetion.
In ontrast, the assumption used in a longevity swap typially reets a best estimate of
future mortality improvements and risk is expliitly allow for via the swap premium rather







B(τ, τ + t)
(q̃x,t −Qx,t)2
q̃x,t
subjet to Equation 32 = 0
where X = {50, 55, 60, 65, 70, 75, 80}. This proedure is equivalent to deter-
mining the market-onsistent measure by referene to an external market in
q-forwards, as proposed in Coughlan et al. (2007) and disussed in Setion
3.3.2 below, if suh as market existed. We onsider these key ages partly to
ensure that the forward mortality surfae in the market-onsistent measure
is biologially reasonable over a wide age range and beause, if a market in
q-forwards does emerge, it is at these ages where the market is likely to be
most liquid (see Li and Luo (2012)). Therefore, the use of the internal market
for longevity risk is simply a proxy for information from an external market
for longevity risk, and will be supplanted should a genuine external market
develop.
We use these assumptions for the external and internal markets for longevity
risk in order to alibrate the parameters of the Essher transform for all ve
models desribed in Setion 2.5. These parameters, along with the forward
mortality surfaes obtained in Setion 2.5, allow us to onstrut the forward
mortality surfae in the market-onsistent measure, whih an then be used
to value other longevity-linked liabilities and seurities in a market-onsistent
fashion.
3.3 Priing longevity-linked seurities
The forward mortality framework desribed above provides a single surfae
of forward mortality rates, alibrated from all the available information on
longevity-linked seurities. It an, therefore, be used to value any other
longevity-linked seurities and give pries onsistent with those observed. We
demonstrate this for a range of dierent longevity-linked seurities below.
3.3.1 Survivor derivatives
Longevity zeros and s-forwards
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In Setion 2.2, we dened the forward mortality rates assuming the exis-
tene of a market in longevity zeros. These were used as they are the funda-
mental seurities dependent upon the survivorship of a ohort of individuals,
and an be used to onstrut more ompliated survivor seurities suh as
annuities and longevity swaps, as disussed below. Related to longevity zeros
are s-forwards, as proposed in Dowd (2003), Blake et al. (2006) and the Life
and Longevity Markets Assoiation,
24
whih are forward ontrats dened on
a longevity zero (and hene are more apital eient).
From Equation 7, we an see that








where Sx,t(τ) is the forward prie of an s-forward at time τ , dened on a o-
hort aged x at τ , with a maturity of t years. Figure 2 shows s-forward pries
dened on the ohort of individuals aged 65 in 2011 with dierent maturities.
As an be seen, most of the models give broadly omparable s-forward
pries, espeially those alibrated using the internal market information. We
note that the LC model gives s-forward pries whih are slightly dierent
from these models, with higher probabilities of survival over the rst few
deades followed by a period of higher mortality rates (and hene a steeper
gradient for the urve), but these are still biologially reasonable.
Annuities
The most relevant longevity-linked instruments for many life insurane
ompanies are annuities. For the reasons disussed in Setion 3.1 and Nor-
berg (2010), individual annuities annot be used to alibrate the forward
mortality surfae in the market-onsistent measure, sine the ashows of
these instruments are expliitly linked to the survivorship of a named indi-
vidual and, hene, their pries inlude an allowane for individual mortality
risk. In addition, they are not traded, and, therefore, annot provide timely






















Figure 2: S-forward pries for ve dierent mortality models
of annuities, the idiosynrati mortality risks are diversiable and so are not
inluded in the value of any spei annuity but through the additional ap-
ital required for the book.
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In addition, modern solveny regimes, suh as
Solveny II, require the best estimate of the liabilities in respet of annuity
poliies to be alulated using market-onsistent assumptions. Therefore, the
market-onsistent forward framework ould, potentially, be used as the basis




There will therefore be a distintion between the prie an annuity is sold to the publi
for and the amount it is reserved for by the life insurer, with the additional margin for
idiosynrati mortality risk harged to the individual forming part of the prot margin of
the produt.
26
This is disussed further in Hunt and Blake (2015j).
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x,τ (τ)B(τ, τ + t) (33)
To alulate the values of longevity zeros beyond the maximum age in our
data, we use the topping out proedure of Denuit and Goderniaux (2005).
We therefore see that annuity values are very losely related to the swap prie
given in Equation 32. We alulate annuity pries
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for men at dierent ages
in 2011 using the ve dierent models, and the results are shown in Figure
3.
We an see from this that the dierent models give broadly similar an-
nuity values. This is not surprising given that they all use the same external
market information (i.e., the swap prie) in order to alibrate the market-
onsistent measure. Indeed, all the models give exatly the same value for
an annuity at age 65, sine this is determined by the swap prie we have
assumed and an annuity is equivalent to the oating leg of a longevity swap.
However, the annuity values given by dierent models diverge slightly as we
move away from this xed referene point, with the LC model giving lower
annuity values at higher ages than the other models.
Index-based longevity swaps
We an also use these results to investigate the potential priing of index-
based longevity swaps at dierent ages. Extending the denition of the swap








x,τ(τ)− (1 + π) tP̃x,τ(τ)
)
B(τ, τ + t) (34)
we an use the same best estimate assumption based on the CMI Proje-
tion Model for the xed legs of the swaps, to alulate the implied swap
27
Annuities are valued using a real disount rate of 1% p.a..
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Figure 3: Annuity values for ve dierent mortality models
premium, π, on index-based longevity swaps at dierent ages. The implied
swap premiums are shown in Figure 4.
As an be seen, the behaviour of the swap premium depends strongly
upon the model being used. For the lassi APC, RP and GP models, whih
inlude a ohort term, the swap premium slightly inreases with age, from
around 4% at age 65 to around 6% between ages 75 and 80 (note that a
value of 4% was assumed at age 65). Swap premiums for the CBDX model
derease slowly with age, to around 3% at age 75. However, for all of these
models, the swap premium remains positive and do not appear unreasonable
at any age.
In ontrast, the LC model gives swap premiums whih derease rapidly
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Figure 4: Swap premiums for ve dierent mortality models
with age, giving negative swap premiums at higher ages (i.e., a premium
would be paid to reeive the oating payments on the swap) whih does not
appear reasonable. This is beause the LC model gives relatively low values
for annuities at higher ages - lower than would be found using the deter-
ministi CMI Projetion Model. We therefore see that there is a trade-o.
On the one hand, we would like to use simple models whih have relatively
few free parameters and so are simple to alibrate from sparse data (and, in
partiular, would avoid the use of an internal market for longevity risk). On
the other hand, we also need to obtain plausible pries for dierent longevity-
linked liabilities and seurities and aross a wide range of ages.
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3.3.2 Other longevity-linked seurities
A number of other longevity-derivatives not based on the survivorship of a
ohort have been proposed, and these an also be valued using the forward
mortality framework proposed here. A number of these are illustrated be-
low. However, the important point to note is that any seurity whih does
not have a non-linear payo (i.e., whih is not an option) an be valued using
the forward mortality framework proposed in this paper.
q-forwards
Forward ontrats on future probabilities of death, known as q-forwards,
were introdued in Coughlan et al. (2007) and represent another, distint,
family of potential longevity-linked seurities. There have been a number of
hedging transations using q-forwards, as disussed in Blake et al. (2013),
and so q-forwards are one of the major ontenders to form the basis of a
traded market for longevity risk if it develops. In addition, the internal mar-
ket assumption, used in Setion 3.2 to alibrate all of the models other than
the LC model, impliitly makes use of a market for q-forwards, albeit one
that is internal to the life insurer rather than an externally traded market.
Values for q-forwards at age 75 and dierent maturities, alulated using
the forward mortality models, are shown in Figure 5, along with the qx,t val-
ues projeted using the CMI Projetion Model. For the models whih used
the internal market assumption to alibrate the market-onsistent measure,
we see that the q-forward values are broadly onsistent with those from the
CMI Projetion Model. However, they are not idential, sine the alibration
proess also has to math the swap prie exatly and minimise the dierene
in q-forward pries at ages other than 75. However, beause the GP model
has more market pries of risk to alibrate, it ahieves a slightly loser t to
the internal market assumption than the other models, inluding the ohort
eet observed around 2025 (i.e., for ohorts born around 1950).
In ontrast, the LC model gives q-forward values whih are very dierent
from those of the other models, with implausibly rapid dereases in q-forward
values. Again, this is beause, with a single market prie for longevity risk,
the LC model has to severely distort the forward mortality surfae in the
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Figure 5: q-forward pries at age 75 for ve dierent mortality models
real-world P-measure in order to prie the longevity swap. It annot ensure
that mortality rates aross a wide range of other ages and years behave in
a plausible fashion in the market-onsistent measure. We therefore see that
more sophistiated underlying APC mortality models, as well as being able
to inorporate priing information from a wider range of soures, will also
tend to give more biologially-reasonable forward surfaes for mortality in
the market-onsistent measure.
e-forwards
Period life expetany is a very ommonly used aggregate measure of
mortality rates, sine it an be alulated easily from observed data and an
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be ompared aross dierent populations. It is, therefore, natural to onsider
its use as an index for longevity risk transfer, based on the suggestion of
Denuit (2009). In partiular, we onsider a market in forwards on period
life expetany, whih we refer to as e-forwards (from the demographi
symbol for period life expetany). Using the forward mortality framework,
we alulate forward period life expetanies as












Figure 6 shows the forward period life expetanies at age 65 from eah of
the ve models in the market-onsistent measure.
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Figure 6: Period life expetanies at age 65 for ve dierent mortality models
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We note that all of the models give forward period life expetanies whih
an be onsidered biologially reasonable and onsistent with the ndings of
Oeppen and Vaupel (2002), i.e., that they inrease roughly linearly. Life
expetanies from the LC model inrease slightly faster than the other mod-
els, whih otherwise give broadly onsistent forward values. This is beause
of the use of the internal market to alibrate these other models, ensuring
greater onsisteny between their forward mortality surfaes.
k-forwards
In Hunt and Blake (2015h), we disussed how the indies based on the
observed rates of improvement in mortality rates, suh as the indies whih
were dened in the onstrution of the Swiss Re Kortis bond, ould poten-
tially form the basis for a market in longevity risk. Improvement rates may
be a natural basis for a market in longevity, as they are often used by atu-
aries to express long term assumptions regarding the evolution of mortality
rates. Building on this, we also onsider the forward value of the index for

















This index was onstruted to measure the average rate of improvement
in mortality rates between ages 75 and 85 for men in the UK and so ould
be used for hedging or transferring longevity risk in a portfolio of annuities.
Unlike the Kortis bond, however, we only onsider an index onstruted for
a single population (i.e., men in the UK) rather than the dierene between
two populations, and only onsider priing the index rather than an option
on the index.
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In Hunt and Blake (2015h) it was suggested that forward ontrats based
on this Kortis index ould form the basis of a market in longevity risk. We
refer to suh ontrats as k-forwards in the same manner at q-, s- and e-
forwards disussed above. Figure 7 shows the projeted k-forward values in
the market-onsistent measure. As disussed in Hunt and Blake (2015h), the
28
See Hunt and Blake (2015h) for a further disussion of the Swiss Re Kortis bond and
its onstrution.
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Figure 7: Kortis index values for ve dierent mortality models
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Kortis index is designed to be very sensitive to the rates of improvement in
longevity, whih are determined by the drift, µ, of the random walk used
for the period parameters. Indeed, for models whih lak a ohort term, the
drift in the random walk exatly determines the projeted index values, and
hene they are onstant beyond 2020.
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For the models whih inlude ohort
parameters, the value of the index in the short term depends strongly upon
the ohort parameters tted by the model, as disussed in Hunt and Blake
(2015h), resulting in a distintive urved pattern. In general, the models
ontaining a ohort term give market-onsistent assumptions for the rate of
improvement in longevity whih derease from its urrently observed level of
around 3.5% to around 2% in 20 years' time. This is not surprising given
this is broadly in line with the assumptions used to alibrate the market-
onsistent measure, i.e., the CMI Mortality Projetion Model with a long
term rate of improvement of either 1.5% or 1.75%.
As in the ase of the q-forwards, the index values for the LC model show a
very dierent evolution due to the limited ability of this model to both prie
the market information and give a biologially reasonable forward surfae of
mortality. However, the alternative models appear to give index values whih
are biologially reasonable and onsistent with the historial, realised values
for the k-forwards, whih potentially means that forwards on the index ould
form a viable basis for a market in longevity risk.
Other longevity-linked seurities
The forward mortality surfae ould also be used to value life assurane
poliies in the same manner. In onjuntion with the results of Hunt and
Blake (2015d), the forward mortality framework ould therefore be used as a
standard model for both the valuation of a life insurer's tehnial provisions
and the assessment of longevity risk within them, in aordane with the
Solveny II regulatory regime desribed in EIOPA (2014). We desribe how
this an be aomplished in Hunt and Blake (2015j). In addition, for life
insurers writing both annuity and assurane poliies, it may be desirable to
value these onsistently in the tehnial provisions, in order to ahieve the
29
Before 2020, the Kortis index is based partly on projeted and partly on observed
mortality rates, and hene exhibits more variability than after 2020.
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benets from natural hedging disussed in Cox and Lin (2007).
Beyond the examples disussed above, the forward mortality framework
ould be used to value any longevity-linked seurity with a linear payo in the
underlying index. Hene, although the market for longevity-linked seurities
is in the early stage of development urrently and it is unlear whih form of
seurities will ultimately ome to be traded, we believe that the framework
desribed in this paper is exible enough to be able to prie any of them in
a manner onsistent with any other pries for longevity-linked liabilities and
seurities whih are available.
As disussed previously, one disadvantage of any forward mortality rate
framework as desribed in this study is that it annot be used to value
longevity-linked options, sine it only looks at the expeted mortality rates
in the market-onsistent measure. For example, it ould not be used di-
retly to value mortality atastrophe bonds, suh as the Swiss Re Vita bond
(disussed in Bauer and Kramer (2007)), Longevity Experiene Options (de-
sribed in Fetiveau and Jia (2014)), bespoke index-based solutions (desribed
in Mihaelson and Mulholland (2014)), a guaranteed annuity option (dis-
ussed in Pelsser (2003) and Ballotta and Haberman (2006)) or a bond sim-
ilar to the Kortis bond with the prinipal being a non-linear funtion of the
index value. At the present time, we do not think that this is a fatal limita-
tion of the forward mortality rate framework disussed here, as urrently the
market for longevity-linked seurities is not suiently developed to allow a
full alibration of the forward mortality rate surfae, let alone the dynamis
of the fore of mortality in the market-onsistent measure, whih is required
to model longevity-linked options. We extend the forward mortality frame-
work developed here to be able to value longevity-linked options in Hunt and
Blake (2015e).
4 Conlusion
The valuation of longevity-linked liabilities and seurities requires us to pre-
dit future rates of mortality. Modern solveny regulations and the gradual
emergene of a market in longevity-linked seurities require these preditions
to inorporate market information, in order to give pries for dierent seu-
rities whih are onsistent with those observed in the marketplae. As many
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previous studies have shown, forward mortality models are ideally plaed to
ahieve this.
We therefore believe that the answer to the titular question raised in
Norberg (2010) - are forward mortality rates the way forward? - is yes. Nev-
ertheless, it is important to take on board the ritiisms of Norberg (2010)
and to develop a framework speially to model mortality rates, rather than
borrow a pre-existing framework developed for interest rates and to dene
this framework using seurities whih do not depend on the idiosynrati
timing of individual deaths. This is beause, with a properly developed
framework, we an derive a model whih is apable of apturing the omplex
dynamis of mortality rates, and so obtain onsisteny between models of
the fore of mortality and the forward mortality rates.
In this study, we have developed suh a framework for forward mortal-
ity rates whih is based upon the dynamis of the fore of mortality given
by the lass of age/period/ohort mortality models. This framework has the
advantage of being easier to estimate from historial data than existing mod-
els, with market information being inorporated via a relatively parsimonious
transformation of the forward mortality rates in the real-world measure. The
framework is also very exible, as it an be used in onjuntion with many
of the most popular models of the fore of mortality, suh as those proposed
in Lee and Carter (1992) and Cairns et al. (2006a).
We have shown how market information an be inorporated into the
model and used the resulting forward mortality surfae to value a range of
existing and proposed longevity-linked seurities. All of the pries alulated
from the same model are onsistent with eah other, as they are derived from
the same forward surfae of mortality. This allows for a unied approah to
the valuation of a wide range of liabilities and longevity-linked seurities.
Finally, we note that the main virtue of forward mortality models is their
ability to speify the dynamis of the forward mortality surfae and, hene,
their appliability to the assessment and management of longevity risk. We
develop these themes in the seond part of this study, in Hunt and Blake
(2015d). Together, these two studies show that the framework proposed an
provide an integrated solution to many of the valuation and risk manage-
ment problems in respet of longevity risk that are faed by life insurane
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ompanies.
A Identiability and mortality forward rates
In Hunt and Blake (2015f) and Hunt and Blake (2015g), we disuss the identi-
ability issues in AP and APC mortality models, respetively. In partiular,
we nd that almost all APC mortality models possess invariant transfor-
mations, i.e., transformations of the parameters of the model whih leave the
tted mortality rates unhanged. In order to nd a unique set of parame-
ters, we impose a set of identiability onstraints on them. Typially, these
are hosen to give a partiular demographi signiane to eah term in the
model. However, sine any interpretation of demographi signiane is sub-
jetive, it is important that our hoie of identiability onstraints does not
have any impat on any onlusions we draw about historial or projeted
mortality rates. For instane, we disuss in Hunt and Blake (2015f,g) how
to ensure that projeted fore of mortality is independent of the hoie of
identiability onstraint.
It is also important that the forward mortality rate framework desribed
in this study is independent of the hoie of identiability onstraints used
when tting the underlying APC model to historial data. However, due to
our denitions of the forward mortality rates in Equation 11, we see that
νPx,t(τ) in the real-world measure is automatially independent of the iden-
tiability onstraints if the distribution of µx,τ is also independent of the
identiability onstraints. We therefore do not need to do any additional
work to ensure identiability in the forward rates one the methods used to
projet the fore of mortality are well-identied.
We also need to ensure that the forward mortality surfae in the market-
onsistent measure is also independent of the hoie of arbitrary identiabil-
ity onstraints. This is mostly straightforward, as we see that Equation 31
depends upon the forward mortality rates in the real-world measure (whih
should be independent of the identiability onstraints for the reasons dis-
ussed above), the varianes of the period and ohort funtions (whih are
independent of the alloation of any levels and linear trends if the proje-
tion methods are well-identied, as disussed in Hunt and Blake (2015g))
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and the market pries of longevity risk. However, we note that if the model
transformed using





then the market pries of risk are also transformed in the model to λ̂ =
(A−1)
⊤
λ. Hene we see that, not only are the values of the market pries of
risk dependent upon the underlying APC model used for the fore of mortal-
ity, they will also depend upon the normalisation sheme and speiation
of the age funtion in the model, and so are not the same aross all models
whih give the same tted mortality rates.
B Impat of Jensen's inequality




















due to the relatively low degree of variability in µx,t, and hene it was shown
in Setion 2.2 that
νx,t(τ) ≈ Eτµx,t
This assumption an be tested numerially, as follows.
For simpliity, we onsider Px,t = Eτ exp(−µx,t). Therefore
Px,t = Eτ exp (− exp (ηx,t))
In Setion 2.3, we assume that
ηx,t ∼ N(Mx,t,Vx,t)
and therefore
Eτ exp(−µx,t) ≈ exp (−Eτµx,t) = exp (− exp (Mx,t + 0.5Vx,t)) (36)
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Holland and Ahsanullah (1989) disussed the log-log distribution, where
X is suh that
ln(− ln(X)) ∼ N(M,V)
We therefore see that Px,τ (τ) is given by the mean of the log-log distribution
if ηx,t is normally distributed. However, the moments of this distribution do
not have a losed form solution. Holland and Ahsanullah (1989) showed that














whih an be omputed numerially.
From Setion 2.3, we see
Mx,t = αx + β⊤xEτκt + Eτγt−x
Vx,t = β⊤xVarτ (κt)βx + Varτ (γt−x)
Hene we an use the results of Holland and Ahsanullah (1989) to om-
pute Px,t numerially, without reourse to the approximation in Equation 36.
Using this, we alulate














numerially and ompare it with the values assumed in Equation 36. This
gives us a hek on the auray of the approximation in Equation 36, whih
underpins the forward mortality framework.
Figure 8 shows the ratio of the numerial value of Px,t alulated using
Equation 37 and the approximate value alulated using Equation 36 for the
ve mortality models onsidered in this paper (in the real-world measure).
We an that in the vast majority of ases, the dierene that the assumption
makes is less than 0.2% (i.e., ratios less than 1.002) and for no ages and
years does the approximation make more than a 1.5% dierene to the for-
ward mortality rates. This is onsistent with the projeted mortality rates
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found in Figure 1, whih also showed that forward mortality rates (using
the approximation) were very lose to those alulated using Monte Carlo
simulations.
The mortality rates whih are most aeted by the approximation are
those at the highest ages and the years of projetion furthest into the future,
whih makes sense as these are the mortality rates with the greatest levels of
unertainty attahed to them. However, they are also the least eonomially
important, sine any ashows that would be aeted by these mortality
rates would be in respet of individuals who are very old (and so there is
very little survivorship to these ages) and far into the future (whih means
that the present value of the aeted ashows would be very small due to
disounting). This gives us reassurane that the approximation in Equation
35 does not systematially distort the results found using the forward mor-
tality framework derived in this paper, ompared with those whih ould be
found using an exat but onsiderably more ompliated framework whih
does not make this assumption.
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